Connect with us

Health & Fitness

Combo DAA May Benefit Patients With Resistant HCV Genotype 3

A meta-analysis of 34 research reports found that direct-acting antiviral (DAA) combo treatment can be effective in achieving sustained virologic response in patients with HCV genotype 3. Medscape Medical News

Published

on

Combo DAA May Benefit Patients With Resistant HCV Genotype 3